Form 15-12G Manitex International,
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-32401
MANITEX INTERNATIONAL, INC.
Exact name of registrant as specified in its charter)
9725 Industrial Drive
Bridgeview, Illinois 60455
(708) 430-7500
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, no par value
(Title of each class of securities covered by this form)
None
(Title of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☒ | |
| Rule 12g-4(a)(2) |
☐ | |
| Rule 12h-3(b)(1)(i) |
☒ | |
| Rule 12h-3(b)(1)(ii) |
☐ | |
| Rule 15d-6 |
☐ | |
| Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice date: Common Stock, no par value: One*
Pursuant to the requirements of the Securities Exchange Act of 1934, Manitex International, Inc. has duly caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: January 13, 2025 | MANITEX INTERNATIONAL, INC. | |||||
| By: | /s/ Joseph Doolan | |||||
| Name: | Joseph Doolan | |||||
| Title: | Chief Financial Officer | |||||
| * | On January 2, 2025, pursuant to the Agreement and Plan of Merger, dated as of September 12, 2024, by and among Manitex International, Inc., a Michigan corporation (the Company), Tadano Ltd., a Japanese corporation (Tadano) and Lift SPC Inc., a Michigan corporation and wholly owned subsidiary of Tadano (Merger Sub), Merger Sub merged with and into the Company, with the Company continuing as the surviving corporation and a wholly owned subsidiary of Tadano. |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
- Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28
- Swarmer Promotes Garrett Kasper to CCO, Realigns Duties Among Executives
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share